Crossmark

Efficacy and safety of vericiguat across the spectrum of heart failure: a systematic review and updated meta‑analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1007/s00228-026-04009-7

Published Online: 2026-03-17

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Batista, Pedro Gomes https://orcid.org/0009-0006-1461-7185
dos Santos Silva, Railla Raquel Albino https://orcid.org/0009-0001-6403-2218
Montenegro, Marcela Vasconcelos https://orcid.org/0000-0001-8939-5026
Huntermann, Ramon https://orcid.org/0009-0005-7890-2615
Molinari, Maria Eduarda https://orcid.org/0009-0004-6827-9404
Samaniego, Miguel Angel https://orcid.org/0009-0002-1833-5346
Dandamudi, Mrunalini https://orcid.org/0009-0001-3580-0783
Fischer Bacca, Caroline O. https://orcid.org/0000-0002-4298-8649
Giorgi, Juliana https://orcid.org/0009-0007-7271-4845
License Information

Text and Data Mining valid from 2026-03-17

Version of Record valid from 2026-03-17
More Information

Article History

Received: 29 October 2025

Accepted: 31 January 2026

First Online: 17 March 2026

Declarations

:

: The authors declare no competing interests.